Clinical trials: Non Specific Low Back Pain
Non-specific Chronic Low Back Pain
Evaluating the Efficacy and Safety of Octane Aether for Treating Chronic Low Back Pain
The goal of this clinical trial is to evaluate the safety of the Octane Aether device and to determine whether the device is effective in treating symptoms of non-specific chronic low back pain in adults.
- Trial name
- NCT07614568
- Testing
- Pulsed electromagnetic field stimulator
- Where
- Canada
- Volunteers
- 24 people
- Sponsor
- Octane Innovation Inc.
Chronic Non-specific Low Back Pain
Dose-Response Characterization of VER-01 in the Treatment of Patients With Chronic Non-specific Low Back Pain
Dose-response characterization of VER-01 in patients with chronic non-specific low back pain (CLBP) for whom drug treatment is indicated and previous optimized treatments with non-opioid analgesics have not led to sufficient pain…
- Trial name
- RESPONSE (NCT06475001)
- Testing
- VER-01
- Where
- United Kingdom
- Volunteers
- 652 people
- Sponsor
- Vertanical GmbH
Chronic Non-specific Low Back Pain
Comparison of VER-01 to Opioids in Patients With Chronic Non-specific Low Back Pain
Randomized, open-label, parallel-group phase III trial to prove an additional benefit of the full-spectrum cannabis extract VER-01 over opioids in patients with chronic non-specific low back pain for whom drug treatment is…
- Trial name
- ELEVATE (NCT05610813)
- Testing
- VER-01, Opioid therapy
- Where
- 2 sites in Germany
- Volunteers
- 384 people
- Sponsor
- Vertanical GmbH
Chronic Non-specific Low Back Pain
Efficacy and Safety of VER-01 in the Treatment of Patients With Chronic Non-specific Low Back Pain
Analysis of the efficacy, maintenance of efficacy, long-term safety, and investigation of the potential for dependence and abuse and the effect of abrupt drug withdrawal of VER-01 in the treatment of patients with chronic…
- Trial name
- NCT04940741
- Testing
- VER-01
- Where
- Germany
- Volunteers
- 820 people
- Sponsor
- Vertanical GmbH
Acute Non-specific Low Back Pain
Milgamma® and Milgamma® Compositum Step-therapy in Patients With Acute Non-specific Low Back Pain Receiving Modern NSAID
The purpose of this study is to assess the effectiveness and safety of add-on Milgamma®/ Milgamma® compositum step-therapy in patients with acute non-specific low back pain receiving modern NSAIDs in routine medical practice.
- Trial name
- NCT03892707
- Testing
- Exposure of interest (within routine clinical practice):Vitamin B complexes Milgamma® and Milgamma® compositum
- Where
- 21 sites in Russia
- Volunteers
- 500 people
- Sponsor
- Woerwag Pharma LLC
Non-specific Chronic Low Back Pain
Home-based Exercise Rehabilitation With a Novel Digital Biofeedback System for Chronic Low Back Pain
The present study is a a single-center, prospective, non-blind, parallel-group, randomized controlled trial, designed to evaluate the clinical impact of a home-based program using a new digital solution on the treatment of…
- Trial name
- NCT04401683
- Testing
- Home-based rehabilitation with a digital biofeedback system, Conventional home-based rehabilitation
- Where
- Portugal
- Sponsor
- Sword Health, SA